1. Product Overview
2.
Research Methodology
3.
Impact of COVID-19 on Saudi Arabia Over-The-Counter (OTC)
Drugs Drugs Market
4. Executive Summary
5. Voice of Customers
6. Saudi Arabia
Over-The-Counter (OTC) Drugs Drugs Market Outlook
6.1.
Market Size & Forecast
6.1.1. By Value
6.2.
Market Share & Forecast
6.2.1. By Product (Cough,
Cold and Flu; Vitamins, Mineral, and Supplements (VMS); Analgesics;
Gastrointestinal Products; Dermatology Products; Others)
6.2.2. By Route of
Administration (Oral, Topical, Parenteral)
6.2.3. By Dosage Form
(Tablets, Capsules, Liquids & Solution, Creams/Lotions/Ointments, Others)
6.2.4. By Distribution
Channel (Retail Pharmacy, Hospital Pharmacy, E-Pharmacy)
6.2.5. By Region
6.2.6. By Company (2021)
6.3. Product Market Map
7. Saudi Arabia Cough,
Cold and Flu Over-The-Counter (OTC) Drugs Drugs Market Outlook
7.1.
Market Size & Forecast
7.1.1. By Value
7.2.
Market Share & Forecast
7.2.1. By Route of
Administration
7.2.2. By Dosage Form
7.2.3. By Distribution
Channel
8. Saudi Arabia
Vitamins, Mineral and Supplements (VMS) Over-The-Counter (OTC) Drugs Drugs Market
Outlook
8.1.
Market Size & Forecast
8.1.1. By Value
8.2.
Market Share & Forecast
8.2.1. By Route of
Administration
8.2.2. By Dosage Form
8.2.3. By Distribution
Channel
9. Saudi Arabia
Analgesics Over-The-Counter (OTC) Drugs Drugs Market Outlook
9.1.
Market Size & Forecast
9.1.1. By Value
9.2.
Market Share & Forecast
9.2.1. By Route of
Administration
9.2.2. By Dosage Form
9.2.3. By Distribution
Channel
10. Saudi Arabia
Gastrointestinal Over-The-Counter (OTC) Drugs Drugs Market Outlook
10.1.
Market Size & Forecast
10.1.1. By Value
10.2.
Market Share & Forecast
10.2.1. By Route of
Administration
10.2.2. By Dosage Form
10.2.3. By Distribution
Channel
11. Saudi Arabia
Dermatology Over-The-Counter (OTC) Drugs Drugs Market Outlook
11.1.
Market Size & Forecast
11.1.1. By Value
11.2.
Market Share & Forecast
11.2.1. By Route of
Administration
11.2.2. By Dosage Form
11.2.3. By Distribution
Channel
12. Market Dynamics
12.1.
Drivers
12.2.
Challenges
13. Market Trends &
Developments
14. Policy & Regulatory
Landscape
15. Saudi Arabia
Economic Profile
16. Competitive
Landscape
16.1.
Competition Outlook
16.2.
Company Profiles
16.2.1. Pfizer Saudi Limited
16.2.2. Sanofi Saudi Arabia
16.2.3. GlaxoSmithKline
Saudi Arabia Limited
16.2.4. Gulf Pharmaceutical
Industries (PSC)
16.2.5. Tabuk Pharmaceutical
Manufacturing Co.
16.2.6. Jamjoom Pharmaceuticals Co
16.2.7. Reckitt Benckiser
(Arabia) FZE
16.2.8. Saudi Pharmaceutical
Industries & Medical Appliances Corporation (SPIMACO)
17. Strategic
Recommendations